Giving Cancer the Brush-Off
WATS3D – a new brush-based biopsy technique combined with computer-assisted analysis – can improve detection rates for pre-cancerous conditions in patients with Barett’s esophagus
Robert Odze | | Longer Read
At a Glance
- Forceps biopsy screening for esophageal pre-cancers has a high degree of sampling error
- Inter-observer variability further limits the protocol’s ability to detect significant disease
- A new technique, WATS3D, combines wide-area trans-epithelial sampling with 3D computer-assisted analysis
- WATS3D reduces sampling error, improves detection of goblet cells and dysplasia with assistance from computer-generated images, and highlights the most atypical areas of tissue
Esophageal cancer may not be among the most common forms of cancer, but it’s certainly one of the most fatal. Only about one in five people diagnosed with esophageal cancer will survive five years (1), and over two-thirds are diagnosed with late-stage disease (2). The key precursor to esophageal cancer is Barrett’s esophagus (BE), a metaplastic change that is often followed by transition to dysplasia. Patients who exhibit signs of BE or esophageal dysplasia (ED) must undergo increased surveillance or ablation so that cancer can be preempted. However, current screening and surveillance technologies are flawed – a dangerous situation for patients at risk for esophageal cancer.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.